Search results
Results from the WOW.Com Content Network
The main aim of screening is to identify risk factors early and adopt preventive measures to reduce morbidity and mortality. [ 1 ] [ 2 ] Early identification of risk factors can lead to timely interventions, such as lifestyle changes, medications, or surgical treatment.
A high score corresponds to a greater risk of stroke, while a low score corresponds to a lower risk of stroke. The CHADS 2 score is simple and has been validated by many studies. [2] In clinical use, the CHADS 2 score (pronounced "chads two") has been superseded by the CHA 2 DS 2-VASc score ("chads vasc" [3]), which gives a better ...
A risk score is a metric used in statistics, biostatistics, econometrics and related disciplines to stratify a population for targeted screening. It assigns scores to ...
Dyslipidemia is a risk factor for the development of atherosclerotic cardiovascular diseases, [1] which include coronary artery disease, cerebrovascular disease, and peripheral artery disease. [1] Although dyslipidemia is a risk factor for cardiovascular disease , abnormal levels do not mean that lipid lowering agents need to be started. [ 2 ]
Inclisiran, sold under the brand name Leqvio, is a medication used for the treatment of high low-density lipoprotein (LDL) cholesterol and for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH).
Because risk scores such as the Framingham Risk Score give an indication of the likely benefits of prevention, they are useful for both the individual patient and for the clinician in helping decide whether lifestyle modification and preventive medical treatment and for patient education, by identifying men and women at increased risk for future cardiovascular events.
In patients with UA/NSTEMI, the TIMI risk score is a prognostication scheme that categorizes a patient's risk of death and ischemic events and provides a basis for therapeutic decision making. [1] TIMI Score Calculation (1 point for each): Age ≥ 65 years; Known coronary artery disease (CAD) (stenosis ≥ 50%) ≥ 3 risk factors for CAD*
Framingham Heart Study physicians. The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts.The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. [1]